Al, M.J.

patient study exacerbation model analysis health value effect treatment probability group parameter cost-effectiveness result number distribution utility trial function uncertainty table mortality scenario disease decision difference ratio program outcome estimate method information smoking change sensitivity tiotropium lung function transplantation survival intervention 0 util sensitivity analysis interval netherland severity class analyses curve hospital approach stage ulcer limit figure omeprazol sample transition period exacerbation frequency population nsaid absence ivf-related absence 0 cost frequency life-year phase situation evaluation dutch change resp esomeprazol state time horizon chapter sample size simulation research physician quality